Cargando…

Dopamine Transporter Imaging in Parkinson Disease: Progressive Changes and Therapeutic Modification after Anti-parkinsonian Medications

Parkinson disease (PD) is a slowly progressive neurodegenerative disease characterized by the loss of dopaminergic neurons and terminals in the nigrostriatal system. Dopamine transporter (DAT) imaging is widely performed for the differential diagnosis of PD and other degenerative parkinsonism from e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ikeda, Ken, Ebina, Junya, Kawabe, Kiyokazu, Iwasaki, Yasuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630131/ https://www.ncbi.nlm.nih.gov/pubmed/30799370 http://dx.doi.org/10.2169/internalmedicine.2489-18

Ejemplares similares

Transdermal Patch of Rotigotine Attenuates Freezing of Gait in Patients with Parkinson's Disease: An Open-Label Comparative Study of Three Non-Ergot Dopamine Receptor Agonists
por: Ikeda, Ken, et al.
Publicado: (2016)

Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders
por: AKDEMİR, Ümit Özgür, et al.
Publicado: (2021)

Clinicoradiological changes of brain NK/T cell lymphoma manifesting pure akinesia: a case report
por: Ishihara, Susumu, et al.
Publicado: (2011)

Unilateral Measles-Associated Retrobulbar Optic Neuritis without Encephalitis: A Case Report and Literature Review
por: Hirayama, Takehisa, et al.
Publicado: (2010)

Rit2 silencing in dopamine neurons drives a progressive Parkinsonian phenotype
por: Kearney, Patrick J., et al.
Publicado: (2023)

Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes
por: Goto, Ryoji, et al.
Publicado: (2023)

Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes
por: Indrieri, Alessia, et al.
Publicado: (2020)

Pilot Study for Correlation of Heart Rate Variability and Dopamine Transporter Brain Imaging in Patients with Parkinsonian Syndrome
por: Warhadpande, Devdutta S., et al.
Publicado: (2022)

No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome
por: Schiebler, Tassilo, et al.
Publicado: (2023)

Evidence for Sprouting of Dopamine and Serotonin Axons in the Pallidum of Parkinsonian Monkeys
por: Gagnon, Dave, et al.
Publicado: (2018)

Review: Subjective Time Perception, Dopamine Signaling, and Parkinsonian Slowness
por: Miyawaki, Edison K.
Publicado: (2022)

Alleviation of Brain Hypoperfusion after Preventative Treatment with Lomerizine in an Elderly Migraineur with Aura
por: Aoyagi, Joe, et al.
Publicado: (2011)

Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease
por: Fiorenzato, Eleonora, et al.
Publicado: (2021)

Sleep deprivation disrupts striatal anti-apoptotic responses in 6-hydroxy dopamine-lesioned parkinsonian rats
por: Ahmadian, Nahid, et al.
Publicado: (2018)

What Mechanisms Are Responsible for the Reuptake of Levodopa-Derived Dopamine in Parkinsonian Striatum?
por: Nishijima, Haruo, et al.
Publicado: (2016)

Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT
por: Mäkinen, Elina, et al.
Publicado: (2019)

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with ((123)I) ioflupane in diagnosis of parkinsonian syndromes
por: Bajaj, Nin, et al.
Publicado: (2013)

Levodopa-Responsive Benign Tremulous Parkinsonism
por: Kano, Osamu, et al.
Publicado: (2013)

30-Month Results of Foetal Dopamine Cell Transplantation into the Brains of Parkinsonian Patients
por: Dymecki, J., et al.
Publicado: (1992)

Impairment of Macroautophagy in Dopamine Neurons Has Opposing Effects on Parkinsonian Pathology and Behavior
por: Hunn, Benjamin H.M., et al.
Publicado: (2019)

Biosignatures for Parkinson’s Disease and Atypical Parkinsonian Disorders Patients
por: Potashkin, Judith A., et al.
Publicado: (2012)

Disorders of the Oral Cavity in Parkinson's Disease and Parkinsonian Syndromes
por: Zlotnik, Yair, et al.
Publicado: (2015)

Eye Movements in Parkinson’s Disease and Inherited Parkinsonian Syndromes
por: Pretegiani, Elena, et al.
Publicado: (2017)

Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes
por: Saeed, Usman, et al.
Publicado: (2020)

Dopamine Transporter Genetic Variants and Pesticides in Parkinson’s Disease
por: Ritz, Beate R., et al.
Publicado: (2009)

Edaravone, a Free Radical Scavenger, Delayed Symptomatic and Pathological Progression of Motor Neuron Disease in the Wobbler Mouse
por: Ikeda, Ken, et al.
Publicado: (2015)

The utility of the combination of a SPECT study with [(123)I]-FP-CIT of dopamine transporters and [(123)I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes
por: Uyama, Naoto, et al.
Publicado: (2017)

Explainable AI to improve acceptance of convolutional neural networks for automatic classification of dopamine transporter SPECT in the diagnosis of clinically uncertain parkinsonian syndromes
por: Nazari, Mahmood, et al.
Publicado: (2021)

Therapeutic efficacy of AAV8-mediated intrastriatal delivery of human cerebral dopamine neurotrophic factor in 6-OHDA-induced parkinsonian rat models with different disease progression
por: Wang, Lizheng, et al.
Publicado: (2017)

“Reframing” dopamine signaling at the intersection of glial networks in the aged Parkinsonian brain as innate Nrf2/Wnt driver: Therapeutical implications
por: Marchetti, Bianca, et al.
Publicado: (2022)

Neurobiology of Depression and Anxiety in Parkinson's Disease
por: Kano, Osamu, et al.
Publicado: (2011)

Pre- and Postsynaptic Dopamine SPECT in Idiopathic Parkinsonian Diseases: A Follow-Up Study
por: Jakobson Mo, Susanna, et al.
Publicado: (2013)

Neural correlates of standing imagery and execution in Parkinsonian patients: The relevance to striatal dopamine dysfunction
por: Mori, Yutaro, et al.
Publicado: (2020)

The network configuration in Parkinsonian state compensates network activity change caused by loss of dopamine
por: Kitano, Katsunori
Publicado: (2023)

Sleep disturbances in Parkinson’s disease are associated with central parkinsonian pain
por: Vila-Chã, N, et al.
Publicado: (2019)

Effects of Anti-Parkinsonian Drugs on Verbal Fluency in Patients with Parkinson’s Disease: A Network Meta-Analysis
por: Zhu, Yuxia, et al.
Publicado: (2022)

Dopamine Transporter Loss in 6-OHDA Parkinson’s Model Is Unmet by Parallel Reduction in Dopamine Uptake
por: Chotibut, Tanya, et al.
Publicado: (2012)

Association of the dopamine transporter gene with Parkinson's disease in Korean patients.
por: Kim, J. W., et al.
Publicado: (2000)

Bupropion Causes Misdiagnosis in Brain Dopamine Transporter Imaging for Parkinsonism
por: Honkanen, Emma A., et al.
Publicado: (2019)

Gastrointestinal Symptoms and Dopamine Transporter Asymmetry in Early Parkinson's Disease
por: Murtomäki, Kirsi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hkjl1melcrm8s36qin280ao7ma